(Q33752765)

29 July 2017

1 reference

title

Defining and measuring quality of diabetes care (English)

1 reference

29 July 2017

Blonde L

1

1 reference

29 July 2017

Dey J

series ordinal

2

1 reference

29 July 2017

Testa MA

series ordinal

3

1 reference

29 July 2017

Guthrie RD

series ordinal

4

1 reference

29 July 2017

language of work or name

1 reference

1 December 1999

1 reference

Primary Care: Clinics in Office Practice

29 July 2017

published in

1 reference

29 July 2017

volume

26

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

841-855

1 reference

Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970134-2

7 January 2021

Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970134-2

7 January 2021

Profiling Outcomes of Ambulatory Care

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970134-2

7 January 2021

Prevention and slowing down the progression of the diabetic nephropathy through antihypertensive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970134-2

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970134-2

7 January 2021

Pressure to treat and pressure to cost: a review of cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970134-2

7 January 2021

Management of dyslipidemia in adults with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970134-2

7 January 2021

Barriers to care in non-insulin-dependent diabetes mellitus. The Michigan experience

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970134-2

7 January 2021

Is the quality of diabetes care better in a diabetes clinic or in a general medicine clinic?

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970134-2

7 January 2021

The Urgent Need to Improve Health Care Quality Institute of Medicine National Roundtable on Health Care Quality

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970134-2

7 January 2021

Service quality in health care

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970134-2

7 January 2021

Progression of renal failure in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970134-2

7 January 2021

Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970134-2

7 January 2021

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970134-2

7 January 2021

Quality of outpatient care provided to diabetic patients. A health maintenance organization experience

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970134-2

7 January 2021

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970134-2

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970134-2

7 January 2021

Assessment of quality-of-life outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970134-2

7 January 2021

Valuing quality of life and improvements in glycemic control in people with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970134-2

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970134-2

7 January 2021

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970134-2

7 January 2021

10.1016/S0095-4543(05)70134-2

Identifiers

DOI

1 reference

29 July 2017

1 reference